Arcus Biosciences RCUS
$15.62 −$0.16 (-1.01%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $15.50 -0.77%
Open$15.66
Prev close$15.78
Day range$15.56 – $16.66
Volume1.67M
Market cap$2.25B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts12
Average target$41.64+166.6% vs. price
- Buy 83%
- Hold 17%
Low $23.00Now $15.62Avg $41.64High $50.00
Recent rating changes
The last 20 actions on file set price targets from $23.00 to $50.00, averaging $41.40.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 9 Nov 2026 | J.P. Morgan | BUY | $40.00 |
| 6 Nov 2026 | Morgan Stanley | HOLD | $23.00 |
| 5 Nov 2026 | Wedbush | BUY | $45.00 |
| 4 Nov 2026 | Citi | BUY | $50.00 |
| 25 Oct 2026 | Citi | BUY | $50.00 |
| 21 Oct 2026 | Truist Financial | BUY | $41.00 |
| 21 Oct 2026 | Citi | BUY | $50.00 |
| 20 Oct 2026 | Mizuho Securities | BUY | $47.00 |
| 20 Oct 2026 | BofA Securities | HOLD | $29.00 |
| 20 Oct 2026 | Morgan Stanley | HOLD | $23.00 |
| 19 Oct 2026 | Goldman Sachs | BUY | $42.00 |
| 15 Oct 2026 | William Blair | BUY | $50.00 |
| 14 Oct 2026 | J.P. Morgan | BUY | $41.00 |
| 13 Oct 2026 | Goldman Sachs | BUY | $42.00 |
| 5 Oct 2026 | BofA Securities | HOLD | $29.00 |
| 3 Oct 2026 | LifeSci Capital | BUY | $46.00 |
| 30 Sep 2026 | Wedbush | BUY | $43.00 |
| 27 Sep 2026 | LifeSci Capital | BUY | $46.00 |
| 25 Sep 2026 | H.C. Wainwright | BUY | $45.00 |
| 24 Sep 2026 | LifeSci Capital | BUY | $46.00 |
No comments yet — be the first to weigh in on RCUS.
Sign in to join the discussion.